Latest Purchase of Amgen (Finally!)
It has been a while since I posted here (despite being very active troubleshooting the dividend portfolio tracker spreadsheet).
On June 8th I added 20 additional shares of the biotechnology company, Amgen (AMGN). This purchase adds on to the already 34 shares that I had, adding an additional $80 per year in dividend income. I was able to purchase it at a share price just below my initial purchase, thereby slightly lowering my cost basis. It is also way off from its 52-week high of 181.
With this purchase my annual dividends are now up to $4828, creeping back close to the $5000 threshold that I had crossed before the dividends cuts of KMI and KKR.
This will probably be my final healthcare-related purchase for awhile now…I already own quite a few healthcare-related stocks and will likely look to diversify into other industries when I have more capital coming in.
Here’s my current healthcare portfolio:
(in current dollar value order)
1) Johnson & Johnson $9970
2) Amgen $8512
3) Gilead Sciences $3877
4) Inovio Pharmaceuticals $2519
5) Esperion Therapeutics $2478
6) Baxter $1433
7) Shire PLC $736
Altogether, they generate about $589 a year in dividends, or about a 2% yield as a whole. Inovio and Esperion do not pay a dividend.